Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Antonio, Texas 78209


Purpose:

Stage 1: To assess the safety, tolerability, pharmacokinetic (PK) profile, and pharmacodynamic (PD) effects of the IW-1973 Tablet administered orally to healthy volunteers, in fed and fasted states, in a single-dose crossover study. Stage 2: To assess the safety, tolerability, PK profile, and PD effects of a range of doses of IW-1973 Tablet administered orally to healthy subjects in a 21-day, multiple ascending-dose study with optional up-titration of dose level within cohort.


Criteria:

Inclusion Criteria: - Subject is an ambulatory male or female between 18 and 55 years old at the Screening Visit - Subject's body mass index score is > 18.5 and < 30.0 kg/m2 at the Screening Visit - Women of childbearing potential must have a negative pregnancy test and must agree to use double-barrier contraception - Subject is in good health and has no clinically significant findings on a physical examination - Other inclusion criteria per protocol Exclusion Criteria: - History of any clinically significant medical condition - Other exclusion criteria per protocol


NCT ID:

NCT02616861


Primary Contact:

Study Director
John Hanrahan, MD
Ironwood Pharmaceuticals


Backup Contact:

N/A


Location Contact:

San Antonio, Texas 78209
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.